Brainwave training boosts network for cognitive control and affects mind-wandering
October 24, 2012 in Neuroscience
A breakthrough study conducted in Canada has found that training of the well-known brainwave in humans, the alpha rhythm, enhances a brain network responsible for cognitive-control. The training technique, termed neurofeedback, is being considered as a promising new method for restoring brain function in mental disorders. Using several neuroimaging methods, a team of researchers at the Western University and the Lawson Health Research Institute have now uncovered that functional changes within a key brain network occur directly after a 30-minute session of noninvasive, neural-based training. Dysfunction of this cognitive-control network has previously been implicated in a range of brain disorders including attention deficit hyperactivity disorder, schizophrenia, depression and post-traumatic stress disorder.
During neurofeedback, users learn to control their own brain activity with the help of a brain-computer interface. In the simplest case, this consists of a computer that records brainwaves through surface sensors on the scalp, known as an EEG (electroencephalogram). The system is then able to process and simultaneously represent a user's real-time brain activity, displayed from moment-to-moment during a training game on a computer. This setup is known as a neurofeedback loop, because information of brain activity is continually fed-back to a user reflecting their level of control. Such real-time feedback allows users to reproduce distinct brain states under physiologically-normal conditions, promising to be an innovative way to foster brain changes without adverse effects. This is possible because of neuroplasticity, a natural property of the brain that enables it to reorganise after continual training, resulting from adjustments to its own activity.
The new findings firstly help to address a long-standing issue in the field: whether neurofeedback training can trigger any brain changes at all? "The effects we observed were durable enough to be detected with functional MRI up to 30 minutes after a session of neurofeedback which allowed us to compare brain and behavioral measures more closely in time," says Tomas Ros, PhD, lead author of the study, now at University of Geneva. "We were excited to find that increased metabolic coupling within a key cognitive network was reflected in the individual level of brainwave change provoked by neurofeedback. The same measures were found to be tightly correlated with reductions in mind-wandering during an attention task. Amazingly, this would imply that the brain's function may be entrained in a direction that is more attentive and quiet. In other words, our findings speak for the exquisite functional plasticity of the adult brain, whose past activity of little more than 30 minutes ago can condition its future state of processing. This has already been hinted at in meditation research, but we arrived at a direct and explicit demonstration by harnessing a brain-computer interface."
Senior author Dr. Ruth Lanius, a professor in the Department of Psychiatry at Western's Schulich School of Medicine & Dentistry and a scientist with Lawson Health Research Institute adds: "Compared to the lack of significant findings in the control group that received training with false feedback, our findings are unambiguously supportive of a direct and plastic impact of neurofeedback on a central cognitive-control network, suggesting a promising basis for its use to treat cognitive disorders. We hope that our observations will stimulate more research by the science community in order to fully evaluate EEG neurofeedback as a viable and potentially revolutionary approach for the treatment of brain disorders. We are very excited by this promise and anticipate a host of new studies in this direction, particularly for cognitive disorders. Our current work has now moved into the clinical domain to examine whether patients with post-traumatic stress disorder may benefit from this advance." The study was directed by Lanius and Dr. Jean Theberge.
Provided by
University of Western Ontario
-
Re-training the brain
Nov 09, 2011 |
not rated yet |
0
-
Dealing with depression
Jun 11, 2012 |
not rated yet |
0
-
Brain training computer game improves some cognitive functions relatively quickly
Jan 11, 2012 |
not rated yet |
0
-
Tuning out: How brains benefit from meditation
Nov 21, 2011 |
not rated yet |
0
-
Researchers gain new insight into prefrontal cortex activity
Mar 05, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
23 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Neuroscience
13 hours ago |
5 / 5 (5) |
0
|
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Neuroscience
16 hours ago |
4.9 / 5 (14) |
0
|
Waiting for a sign? Researchers find potential brain 'switch' for new behavior
You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...
Neuroscience
17 hours ago |
5 / 5 (1) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
Neuroscience
18 hours ago |
4.2 / 5 (5) |
0
|
Study shows where scene context happens in our brain
In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...
Neuroscience
20 hours ago |
4 / 5 (1) |
0
|
Study says empathy plays a key role in moral judgments
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.